Leading ATE manufacturer in North Reading, MA, serving top tech clients like Samsung and Intel.
teradyne.comCrawled Oct 14, 2026
Superior performance bus test instruments designed to address the unique functional test requirements of real-time test and emulation
The ETS-364 is a precision analog and mixed-signal test platform designed for high volume production testing of integrated circuits.
The IP750Ex-HD delivers image sensor test capability for current and future devices while providing the lowest cost of test. Advantages & Configurations:
Teradyne's Magnum V systems delivers high throughput and high parallel test efficiency for ultra-high performance NAND Flash testing and DRAM memories.
The page features company blogs written and published by experts in their subject fields.
As everyone shifts to the 5G Connectivity, learn more about Teradyne’s role in harbouring change for the wireless future. Paving way for higher connectivity.
Teradyne's newsroom features company news, industry events it attends, and product photography.
From idea to final product – Teradyne brings the next generation of technology to market through advanced test and automation solutions
Teradyne says it is committed to creating a positive workplace, reducing the impact of its operations, and supporting surrounding communities.
Teradyne provides contact by email, phone, and office visits.
Teradyne offers technological solutions for modern problems.
Teradyne China says it processes personal data in accordance with applicable laws and regulations, including China's Personal Information Protection Law and Cybersecurity Law.
Teradyne's privacy statement describes how it collects, protects, and uses website visitors' personal information.
Multiply Labs raises $75 million in a Series B led by medical researcher Patrick Soon-Shiong, with AstraZeneca and robotics maker Teradyne among more than half a dozen other backers. Its robotics clusters use robotic arms, specialized enclosures and customer-trained AI to automate pharmaceutical production steps while imitating existing manual workflows. The company focuses on cell and gene therapies, says its technology can increase throughput 100-fold and lower cost per dose by 74%, and plans to expand therapy support and production capacity.
Oct 2026 · SiliconANGLENews article